Genomic alterations of human gliomas detected by restriction landmark genomic scanning.
Alterations of genomic DNA in eight primary astrocytic tumors and two glioma cell lines were examined using a recently developed two-dimensional gel electrophoresis method called restriction landmark genomic scanning (RLGS). RLGS allows us to detect amplifications, deletions, and methylation in genomic DNA in one procedure without requiring any polymorphic markers. Approximately 2000 spots (landmark sites) in tumor specimens were compared with those in normal brain tissue. The 10 spots with intensified signal were reproducibly detected in at least 50% of primary tumors, implying amplification of corresponding DNA sequences. Conversely, 12 spots with reduced signal were observed in more than 50% of all tumors, suggesting inactivation by allelic loss, homozygous deletion, or CpG island methylation. These results suggest that common genetic alterations are closely correlated with the genesis or progression of human gliomas.
Nakamura
M
M
Department of Neurosurgery, Nara Medical University, Japan. nkonishi@nmu-gw.cc.naramed-u.ac.jp
Konishi
N
N
Tsunoda
S
S
Hiasa
Y
Y
Takemura
K
K
Tsuzuki
T
T
Kobitsu
K
K
Sakaki
T
T
D001932:Brain Neoplasms / Q000235:genetics*; D004273:DNA, Neoplasm / Q000032:analysis; D015972:Gene Expression Regulation, Neoplastic; D005910:Glioma / Q000235:genetics*; D006801:Humans; D015183:Restriction Mapping / Q000379:methods*; D014407:Tumor Cells, Cultured
D004273:DNA, Neoplasm